Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species
- 1 January 1996
- journal article
- other
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 24 (1) , 59-60
- https://doi.org/10.1016/0732-8893(95)00149-2
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and EnterococciDiagnostic Microbiology and Infectious Disease, 1995
- Emerging multiply resistant enterococci among clinical isolates I. Prevalence data from 97 medical center surveillance study in the United StatesDiagnostic Microbiology and Infectious Disease, 1995
- In vitro antimicrobial susceptibility of glycopeptide-resistant enterococciDiagnostic Microbiology and Infectious Disease, 1995
- Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centersJournal of Clinical Microbiology, 1994
- In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organismsAntimicrobial Agents and Chemotherapy, 1993